High- and intermediate-methylation epigenotypes strongly correlated with BRAF and KRAS mutations, respectively, and low-methylation epigenotype correlated with the absence of these oncogene mutations, suggesting the existence of at least three distinct pathways in the genesis of CRC. This evidence concerns the gene BRAF and colorectal carcinoma.